Search by Drug Name or NDC
NDC 00409-4277-02 Lidocaine Hydrochloride 20 mg/mL Details
Lidocaine Hydrochloride 20 mg/mL
Lidocaine Hydrochloride is a INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-4277 |
|---|---|
| Product ID | 0409-4277_1d346dc9-3408-4971-8cd5-79c2527eee5f |
| Associated GPIs | 69100040102020 |
| GCN Sequence Number | 003405 |
| GCN Sequence Number Description | lidocaine HCl VIAL 20 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 11857 |
| HICL Sequence Number | 001478 |
| HICL Sequence Number Description | LIDOCAINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LIDOCAINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA088327 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-4277-02 (00409427702)
| NDC Package Code | 0409-4277-02 |
|---|---|
| Billing NDC | 00409427702 |
| Package | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-4277-02) / 50 mL in 1 VIAL, MULTI-DOSE (0409-4277-17) |
| Marketing Start Date | 2005-08-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |